Search by Drug Name or NDC
NDC 33342-0115-51 Candesartan 8 mg/1 Details
Candesartan 8 mg/1
Candesartan is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Macleods Pharmaceuticals Limited. The primary component is CANDESARTAN CILEXETIL.
MedlinePlus Drug Summary
Candesartan is used alone or in combination with other medications to treat high blood pressure. Candesartan is also used alone or in combination with other medications to treat congestive heart failure (a condition when your heart can not pump enough blood to the other parts of the body). Candesartan is in a class of medications called angiotensin II receptor antagonists. It works by blocking the action of certain natural substances that tighten the blood vessels, allowing the blood to flow more smoothly and the heart to pump more efficiently. High blood pressure is a common condition, and when not treated it can cause damage to the brain, heart, blood vessels, kidneys, and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 33342-0115-51Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Candesartan
Product Information
| NDC | 33342-0115 |
|---|---|
| Product ID | 33342-115_4079c843-42ee-4f7a-a4a0-9498ba6cf12d |
| Associated GPIs | 36150020100320 |
| GCN Sequence Number | 037016 |
| GCN Sequence Number Description | candesartan cilexetil TABLET 8 MG ORAL |
| HIC3 | A4F |
| HIC3 Description | ANTIHYPERTENSIVES, ANGIOTENSIN RECEPTOR ANTAGONIST |
| GCN | 73543 |
| HICL Sequence Number | 016913 |
| HICL Sequence Number Description | CANDESARTAN CILEXETIL |
| Brand/Generic | Generic |
| Proprietary Name | Candesartan |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Candesartan |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 8 |
| Active Ingredient Units | mg/1 |
| Substance Name | CANDESARTAN CILEXETIL |
| Labeler Name | Macleods Pharmaceuticals Limited |
| Pharmaceutical Class | Angiotensin 2 Receptor Antagonists [MoA], Angiotensin 2 Receptor Blocker [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA203813 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 33342-0115-51 (33342011551)
| NDC Package Code | 33342-115-51 |
|---|---|
| Billing NDC | 33342011551 |
| Package | 300 TABLET in 1 CONTAINER (33342-115-51) |
| Marketing Start Date | 2016-12-06 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |